Baseline High-Resolution CT Findings Predict Acute Exacerbation of Idiopathic Pulmonary Fibrosis: German and Japanese Cohort Study
暂无分享,去创建一个
N. Kohno | K. Awai | H. Kühl | N. Shime | H. Iwamoto | N. Hattori | F. Bonella | U. Costabel | S. Ohshimo | K. Fujitaka | Y. Horimasu | J. Guzman | D. Komoto | H. Hamada | Chihiro Hirano
[1] Takeshi Johkoh,et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , 2018, American journal of respiratory and critical care medicine.
[2] H. Collard,et al. Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis , 2017, European Respiratory Journal.
[3] Johan Coolen,et al. Thin-Section CT Features of Idiopathic Pulmonary Fibrosis Correlated with Micro-CT and Histologic Analysis. , 2017, Radiology.
[4] H. Taniguchi,et al. Subgroup analysis of Asian patients in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis , 2016, Respirology.
[5] Y. Obase,et al. Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis , 2016, Respiratory Research.
[6] H. Collard,et al. Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS. , 2016, American journal of respiratory and critical care medicine.
[7] S. Nathan,et al. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis , 2015, BMC Pulmonary Medicine.
[8] S. Kudoh,et al. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in Japan. , 2015, Respiratory investigation.
[9] K. Sugino,et al. Comparison of clinical characteristics and outcomes between combined pulmonary fibrosis and emphysema associated with usual interstitial pneumonia pattern and non-usual interstitial pneumonia. , 2015, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[10] M. Zorzetto,et al. Facts and promises on lung biomarkers in interstitial lung diseases , 2015, Expert review of respiratory medicine.
[11] N. Kohno,et al. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis , 2015, Respirology.
[12] Ivana V. Yang,et al. The MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in a Mexican cohort but is rare among Asian ancestries. , 2015, Chest.
[13] M. Bando,et al. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. , 2014, American journal of respiratory and critical care medicine.
[14] H. Collard,et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. , 2014, The New England journal of medicine.
[15] H. Collard,et al. Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure , 2013, European Respiratory Journal.
[16] H. Collard,et al. Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials , 2013, Respiratory Research.
[17] I. Noth,et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. , 2013, JAMA.
[18] Y. Kanda,et al. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.
[19] N. Sverzellati,et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study , 2012, European Respiratory Journal.
[20] J. Egan,et al. Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis , 2011, European Respiratory Journal.
[21] Jianhua Yao,et al. Automated quantification of high-resolution CT scan findings in individuals at risk for pulmonary fibrosis. , 2011, Chest.
[22] I. Yoshino,et al. Risk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomography , 2011, Surgery Today.
[23] Ivana V. Yang,et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. , 2011, The New England journal of medicine.
[24] Jong-Min Song,et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome , 2010, European Respiratory Journal.
[25] T. Kozuka,et al. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. , 2008, American journal of respiratory and critical care medicine.
[26] N. Müller,et al. Fleischner Society: glossary of terms for thoracic imaging. , 2008, Radiology.
[27] Gary K Grunwald,et al. Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality. , 2008, Radiology.
[28] N. Müller,et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. , 2008, American journal of respiratory and critical care medicine.
[29] H. Collard,et al. Acute exacerbations of idiopathic pulmonary fibrosis. , 2007, American journal of respiratory and critical care medicine.
[30] A. Nicholson,et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features , 2006, European Respiratory Journal.
[31] N. Müller,et al. Idiopathic pulmonary fibrosis: spectrum of high-resolution CT findings. , 2005, AJR. American journal of roentgenology.
[32] P. Brillet,et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity , 2005, European Respiratory Journal.
[33] David A Lynch,et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. , 2005, American journal of respiratory and critical care medicine.
[34] Paul J. Friedman,et al. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.
[35] John L. Hankinson,et al. Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[36] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[37] Ivana V. Yang,et al. A Common MUC 5 B Promoter Polymorphism and Pulmonary Fibrosis , 2011 .
[38] D. Schroeder,et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. , 2010, Chest.
[39] A. Buist. Standardization of spirometry. , 1987, The American review of respiratory disease.